According to Telomir Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.12. In 2022 the company made an earnings per share (EPS) of -$0.02885 a decrease over its 2021 EPS that were of -$0.004665.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.12 | 317.41% |
2022 | -$0.02885 | 518.37% |
2021 | -$0.004665 |